MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics, Inc. (SNSE)

|||

Balance Sheets Overview

Current Ratio
1439.27%
Quick Ratio
1439.27%
Cash Ratio
1073.47%
Debt to Asset Ratio
6.91%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Series b redeemable convertible ...
    • Additional paid-in capital
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
152,325
8,668
10,562
12,557
Marketable securities
50,468
12,516
14,479
16,071
Prepaid expenses
974
231
496
828
Other current assets
465
92
248
116
Total current assets
204,232
21,507
25,785
29,572
Right of use assets - operating leases, net
913
1,294
1,668
2,034
Right of use assets - financing leases, net
0
1
6
10
Property and equipment, net
69
82
112
143
Other non-current assets
167
18
18
24
Total assets
205,381
22,902
27,589
31,783
Accounts payable and accrued expenses
8,982
1,481
1,405
1,135
Compensation and employee benefits liabilities
4,169
1,320
1,156
775
Operating lease liabilities, current
1,021
1,370
1,682
1,622
Financing lease liabilities, current
18
80
193
341
Total current liabilities
14,190
4,251
4,436
3,873
Operating lease liabilities, non-current
0
59
146
592
Financing lease liabilities, non-current
-
0
0
4
Other non-current liabilities
1
-
-
-
Total liabilities
14,191
4,310
4,582
4,469
Series b redeemable convertible preferred stock, 0.0001 par value 25,045 and 0 shares authorized as of march 31, 2026 and december 31, 2025, respectively 24,937 and 0 shares issued and outstanding as of march 31, 2026, and december 31, 2025, respectively liquidation value of 0 as of march 31, 2026
328,476
-
-
-
Additional paid-in capital
316,111
301,728
301,431
301,177
Accumulated deficit
-453,373
-283,137
-278,421
-273,852
Accumulated other comprehensive (loss) income
-24
1
-3
-11
Total stockholders' (deficit) equity
-137,286
18,592
23,007
27,314
Total liabilities, redeemable convertible preferred stock, and stockholders' (deficit) equity
205,381
22,902
27,589
31,783
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$152,325K Marketable securities$50,468K Prepaid expenses$974K Other current assets$465K Total current assets$204,232K Right of use assets -operating leases, net$913K Other non-currentassets$167K Property and equipment,net$69K Total assets$205,381K Accumulated deficit-$453,373K Accumulated othercomprehensive (loss) income-$24K Total liabilities,redeemable convertible...$205,381K Total stockholders'(deficit) equity-$137,286K Additional paid-in capital$316,111K Series b redeemableconvertible preferred...$328,476K Total liabilities$14,191K Total currentliabilities$14,190K Other non-currentliabilities$1K Accounts payable andaccrued expenses$8,982K Compensation and employeebenefits liabilities$4,169K Operating leaseliabilities, current$1,021K Financing leaseliabilities, current$18K